Mussel Polymers, Inc.

Biotech Bethlehem, PA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Bethlehem, PA
Street
116 Research Drive
Zip
18015

Offering

Total offering
$4.8M
Amount sold
$4.8M
First sale
Dec 31, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 504
Investors so far
51

How this filing compares

Ranked #11 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.9× the median.

Other Pennsylvania filings this week: 4401 Fund 4 LLC, Paragon Laboratories L.P., SEMPER VIC PARTNERS (QP), L. P., SEMPER VIC PARTNERS, L.P., 6 EMERY OWNER LLC

Leadership

George Boyajian — Executive Officer (also: Director)

Eric Anderson — Director

Kevin Ohashi — Director

Filing details

Mussel Polymers, Inc. filed a Form D with the SEC on March 30, 2026.

Other newest Biotech companies

Other newest companies in Pennsylvania